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Background: Dissemination and implementation of health care interventions are currently hampered by the
variable quality of reporting of implementation research. Reporting of other study types has been improved by
the introduction of reporting standards (e.g. CONSORT). We are therefore developing guidelines for reporting
implementation studies (StaRI).
Methods: Using established methodology for developing health research reporting guidelines, we systematically
reviewed the literature to generate items for a checklist of reporting standards. We then recruited an international,
multidisciplinary panel for an e-Delphi consensus-building exercise which comprised an initial open round to
revise/suggest a list of potential items for scoring in the subsequent two scoring rounds (scale 1 to 9). Consensus
was defined a priori as 80% agreement with the priority scores of 7, 8, or 9.
Results: We identified eight papers from the literature review from which we derived 36 potential items. We recruited 23
experts to the e-Delphi panel. Open round comments resulted in revisions, and 47 items went forward to the scoring
rounds. Thirty-five items achieved consensus: 19 achieved 100% agreement. Prioritised items addressed the need to:
provide an evidence-based justification for implementation; describe the setting, professional/service requirements,
eligible population and intervention in detail; measure process and clinical outcomes at population level (using routine
data); report impact on health care resources; describe local adaptations to the implementation strategy and describe
barriers/facilitators.
Over-arching themes from the free-text comments included balancing the need for detailed descriptions of interventions
with publishing constraints, addressing the dual aims of reporting on the process of implementation and effectiveness of
the intervention and monitoring fidelity to an intervention whilst encouraging adaptation to suit diverse local contexts.
Conclusions: We have identified priority items for reporting implementation studies and key issues for further discussion.
An international, multidisciplinary workshop, where participants will debate the issues raised, clarify specific items and
develop StaRI standards that fit within the suite of EQUATOR reporting guidelines, is planned.
Registration: The protocol is registered with Equator: http://www.equator-network.org/library/reporting-guidelines-under-
development/#17.
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The UK Medical Research Council (MRC) provides
guidance to help funders, researchers and policymakers
make appropriate decisions in relation to developing,
evaluating and implementing complex interventions [1].
Randomised controlled trials (RCTs), the gold standard
of research designs for assessing the efficacy/effective-
ness of interventions [2], are typically delivered under
tightly controlled conditions, with carefully selected,
highly motivated, fully informed and consented partici-
pants, and typically follow detailed and relatively rigid
protocols to avoid the influence of confounding variables
and limit the impact of bias [3,4]. Implementation stud-
ies that accommodate - or even encourage - diversity of
patient, professional and health care contexts in order to
inform implementation in real-life settings are relatively
uncommon [5]. Using a range of methodologies [1], imple-
mentation interventions are delivered within the context of
routine clinical care and accessible to all patients clinically
eligible for the service (as opposed to participants select-
ively recruited into a research study). By comparing a new
service/procedure with the existing/previous regime, and
assessing process, clinical and population level outcomes
[6,7], they provide practical information about the impact
on time and resources, the training requirements and work-
place implications of implementing interventions into rou-
tine care [4,8]. They are useful study designs when
developing policy recommendations [7].
The standard of reporting of implementation studies
has been criticised as being incomplete and imprecise
[9-11]. Specific issues include inconsistent use of termin-
ology making it difficult to identify sensitive and specific
terms for search strategies [5], a lack of clarity about the
methodology making it difficult to determine if a study
was testing the implementation of an initiative, and a
poor description of the intervention being implemented
so that replication would not be possible [12]. Introduc-
tion of the consolidated standards of reporting trials
(CONSORT) checklist [13,14] has standardised the report-
ing of trials, with some evidence that standards have
improved [15-19]. The success of this initiative has encour-
aged the development of further reporting standards, but
although some can inform aspects of implementation sci-
ence (e.g. observational studies [19], quality improvement
studies [20] and non-randomised public health interven-
tions [21]), none adequately address the reporting of imple-
mentation studies [11]. To address this gap, we are
developing the standards for reporting implementation
studies (StaRI) statement [22], the first phases of which
were a literature review and e-Delphi exercise.
Methods
We followed the methodology described in the guidance
for developing health research reporting guidelines [23].A more detailed description of our methods is available
on the EQUATOR website [22].
Literature review in order to identify potential standards
We undertook a literature review to identify evaluations
of the standard of implementation study reporting and
expert opinion on current design and reporting practice.
We searched the MEDLINE database, using guideline
terms such as ‘standard*’, ‘guidance’; ‘framework’; ‘report-
ing guideline*’; (report* ADJ GOOD ADJ PRACTICE)
AND study design such as ‘implementation’; ‘implemen-
tation science’; ‘Phase IV’; ‘Phase 4’; ‘real-life’; ‘routine
clinical care’; (‘real-world’ or ‘real world’ or routine or
nationwide) adj1 (setting* or practice or context). We ex-
plored existing EQUATOR statements [13,14,19-21] and
undertook snowball searches from their reference lists
and, in addition, hand searched the Journal of Implemen-
tation Science, Pragmatic and Observational Research,
Quality and Safety in Healthcare.
We identified potential standards from the literature
review and collated them as possible standards for inclu-
sion in a StaRI Statement.
International expert panel
We recruited, by e-mail, an international expert panel to
include professionals involved with the design and evalu-
ation of complex interventions [1], journal editors from
high impact general and implementation specific jour-
nals, researchers who have published high-profile imple-
mentation research, representatives of funding bodies,
guideline developers and authors of related EQUATOR
standards [13].
e-Delphi exercise to identify and prioritise standards
Originating from the RAND Corporation in the 1950s
[24], the Delphi method is a technique in which an ex-
pert panel contributes ideas and then ranks suggestions
in successive rounds until pre-defined consensus is
reached [25-27]. The panellists work independently, and
their contributions are anonymous, but in each round,
responses are influenced by summary feedback from
previous rounds. We used Clinvivo systems [www.clin-
vivo.com] to facilitate the web-based process, which
(following piloting by the study team to ensure optimal
terminology and clarity) involved an open round and
two scoring rounds. Participants were encouraged to
complete all rounds of the exercise.
Open round
The first round invited the expert panel to contribute
potential standards which should be required in report-
ing implementation studies. To aid deliberation, we
provided the provisional standards derived from the
literature review, collated under appropriate headings
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description of setting, recruitment, intervention, out-
comes and data collection, presentation of results and
interpretation). Ample free text space was provided to
enable participants to provide their own suggestions and
to comment on the exemplars.
Responses were collated by HP, reviewed by the re-
search team, and a checklist of potential items derived
for ranking in the first scoring round.First scoring round
Panel members were asked to score each item on the
checklist on a scale of 1 to 9 (i.e. least important to
very important). There was an opportunity at the end
of each section of the checklist to add any comments
or suggest any further standards that the respondent
felt should be considered. Reminders were sent a few
days before and immediately after the 2-week dead-
line. The median score and a graphical display of the
distribution of responses were prepared for feedback
in the next round.Second scoring round
Participants who completed the first scoring round were
sent a second round checklist in which the median re-
sult from the first scoring round was listed alongside the
participant’s own score for each item. Participants were
invited to reconsider the importance of the standards
and confirm or revise their score in the light of the
group opinions. Reminders were sent a few days before
and immediately after the 2-week deadline.
We anticipated that two scoring rounds would allow
an acceptable degree of agreement on priority items, but
if not, a final third scoring round was planned. This
would follow the format of the second scoring round,
but omit items that had 80% agreement with the low
priority scores of 1, 2, or 3.Quantitative analysis of scoring
Participants were advised that scores of 7 to 9 were de-
fined as indicating that they had ‘prioritised’ that item,
and conversely, scores of 1 to 3 were defined as ‘rejec-
tion’ of an item. We calculated the proportion of respon-
dents prioritising each item: consensus was defined as
80% agreement for the priority score of 7 or more.Figure 1 PRISMA flow chart.Qualitative analysis of free-text comments
The free text comments from the open round and the
two scoring rounds were coded (by HP and reviewed by
the research team) and thematically analysed to identify
the key issues from the perspective of the participants.Results
Literature review initial list of potential standards
See Figure 1 for the PRISMA flow chart. We screened
the titles and abstracts of 127 papers and included six
for full-text screening. Snowball searches from these six
identified a further seven papers. Five of these 13 papers
were excluded because on reading the full text, they did
not discuss standards of reporting implementation stud-
ies. We thus included nine papers: four were discussion
papers [4,11,28,29], two were editorials [7,10], two were
methodological papers [9,30] and one was an online
source [31]. The common theme was the importance of
improving the standard of reporting in implementation
research.
Table 1 summarises the standards identified from the
literature review. We collated these to define a list of 36
suggested items which were included as exemplars in
the initial e-Delphi process.
International expert panel
Of the 66 international experts approached, 23 agreed to
participate and contributed to the open round. Some
were invited by virtue of their position in an organisa-
tion, and we accepted their suggested deputies if they
personally were unable to help. The resultant panel was
international (United Kingdom (n = 12), United States
(n = 7), Australia and New Zealand (n = 2), Netherlands
Table 1 Summary of checklist items suggested by the
literature
Checklist
section
Suggested checklist item
Introduction
Background Report the care or quality gap (e.g. failure to
implement guidelines) that the intervention seeks to
address [29].
Report the evidence behind the intervention to be
implemented (e.g.: RCTs, controlled trials, systematic
reviews) [11,29].
Report the theory behind the intervention [10,31,29]
and how the theory influenced the study design [10].
Methods
Setting Describe the study setting [10,11,31].
Describe any changes or modifications required to
adjust to the intervention [7,10].
Report readiness to change (also those not eager to
change) [29].
How did the setting enable or hinder the
implementation? [10]
Participants Report method of recruitment [4] which should be to
the clinical service not the research [11]. Participants
recruited to research should be considered as a
sub-group [11].
Intervention Provide detailed description of intervention strategies:
Components/content for each group [10,31,29].
Frequency [10], duration [4,10,31,29] and intensity
[10,31,29] of the intervention
Mode of delivery [31,29] and materials used [31,29].
What is the relationship of components to the theory
discussed above? [10]
What is the target population? [4,11]
Provide details of participants receiving the intervention
(eligibility criteria?) [10,11,31].
Provide detailed characteristics of those promoting and
undertaking the intervention [4,10,31].
What were the processes for ensuring intervention
fidelity? [4,7,10,31]
Describe the intervention received by control group
(not just describe as ‘usual care’) [31].
The intervention must be delivered as part of routine
care [11].
Analysis Describe measurements used to assess implementation
effectiveness [29].
Outcomes should be assessed at the population level,
typically with routine data [11]. Describe methods of
statistical analysis [31,29].
Results
Participant
flow
Report the process by which eligible patients were
invited to participate (e.g. number invited and
timescale) and any exclusions [4].
Report participation rate among the eligible population
[4,11] and the representativeness of participants
compared to whole eligible population [4].
Table 1 Summary of checklist items suggested by the
literature (Continued)
Setting Report characteristics of the setting to enable
assessment of representativeness [4].
Intervention Cost of the intervention [4].
Report any modifications or adaptation [4,11,28].
Report any intervention feasibility, acceptability, and
potential sustainability [28].
Discussion
Reflections Reflect on the implementation process [10,11].
Report any lessons learned from the implementation
process [10].
Report any barriers or facilitators for implementing in
routine care [9].
Discuss the relationship between adaptations/
modifications and treatment outcomes,
implementation outcomes and adverse events [28].
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19), journal editors (n = 7), health care professionals (n = 5)
methodologists (n = 6), guideline developers (n = 3), charity
funders (n = 3), health care managers (n = 2) and national
funding bodies (n = 2): many participants contributed more
than one perspective).
Twenty respondents (87%) completed the first scoring
round and 19 (83%) completed the second scoring round.
e-Delphi exercise to identify and prioritise standards
Open round
All the 36 items suggested by the literature review
attracted comment (both agreement and disagreement),
and additional suggestions were made. As a result of
these comments, four of the original items were rejected,
23 were revised and 15 additional items were included.
A total of 47 potential items thus went forward to the
scoring rounds.
Consensus (scoring rounds)
Table 2 lists the 35 items that achieved the a priori level
of consensus for inclusion, i.e. 80% agreement with
scores 7, 8 or 9: 19 items achieved 100% agreement. No
items were rejected by 80% of the respondents: most of
the others (see Table 3) scored in the equivocal range of
4, 5 or 6.
Over-arching issues raised by the expert panel
In addition to specific comments related to individual
items, thematic analysis of the free text comments re-
vealed a number of over-arching issues
Dual aims of implementation and effectiveness
A distinction was made between the assessment of im-
plementation (measured by process outcomes) and
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comes) with most comments supporting the concept
that both constructs were important in implementation
research. Cost-effectiveness was specifically highlighted
as essential information for health services.
‘This should clarify the “effectiveness aims” from the
“implementation aims.”’ [Open round comment]‘Analyses must examine impacts/outcomes as well as
processes’ [Open round comment]‘[Cost-effectiveness] is important for (governmental)
health agencies, funding agencies, insurance
companies, but also for healthcare centres and health
researchers themselves’ [Open round comment]
Balancing the need between detailed descriptions and the
risk of overload
Nine of the 35 prioritised items focussed on the require-
ment for a description of the novel features of the inter-
vention, including details of the setting, the target
population, stakeholder engagement and service delivery.
These details were described by the expert panel as ‘use-
ful’, and comprehensive descriptions were considered to
be ‘ideal’ as they enabled ‘a better judgement to be made
about the added value of the new service’, however, it
was widely recognised that space restrictions in a journal
article might make detailed descriptions impractical espe-
cially for ‘large-scale interventions’. A number of alterna-
tive strategies were suggested including a ‘brief description
in the methodology section’ and providing details in a sep-
arate paper, an appendix or ‘web extra’ or ‘available from
the authors on request’.
‘Sorry, lots of essentials in my response. Hard to say
much shouldn't be there really, good suggestions for a
reporting standard’ [First scoring round comment]‘Only concerns - all individual items are fine - is the
overall cumulative burden compared to journal space
usually available’ [Open round comment]
Fidelity to the intervention vs. adaptation to the new service
The item related to fidelity and the item reflecting modi-
fication and/or adaptation of the intervention both
achieved 100% consensus as priority items, though they
both generated a range of comments. In general, fidelity
and adaptation were seen as separate, equally important
constructs, though at least one respondent considered
that they could be combined as they both reflected
whether the intervention was ‘delivered as intended’.
Some comments linked fidelity with ‘standardisation’
and suggested that variation was ‘a failure to adhere tointended service model’. Others emphasised the inevit-
ability (or even desirability) that an intervention would
be adapted by different settings and advocated using
‘non-judgemental’ terminology to describe the diversity
of implementation. Time was identified by several re-
spondents as an additional dimension. It was also
highlighted that modifications could be ‘unintended’ as
well as planned variation between centres.
‘Also the concept of fidelity and implicit demand to
not report variations - which we know happen every-
where’. [Open round comment]‘It is inevitable that changes will be made to the
service and so the assumption should be that changes
will occur and that these need to be described’ [Open
round comment]‘Need to allow for change in intervention over time as
well as local adaptability - these [questions] assume new
service is fixed in aspic’ [First scoring round comment]
The importance of describing in some detail the situ-
ation in the comparator groups was also emphasised as
this could ‘be very different from place to place’.
‘Components of the new strategy may be part of the
“usual care” given in one centre but not in another.’
[Second scoring round comment]
Overlap with other reporting guidelines
A number of comments referred to the large number of
existing reporting standards (‘over 25 archived on the
EQUATOR network already’ [13]), and a number of re-
spondents raised concerns about overlap with CONSORT
[14], STROBE [19], COREQ [32], TIDieR [33] and the ‘dan-
ger of “publication guideline fatigue” amongst investigators
and journal editors’. It was emphasised that StaRI ‘will need
to be clear where it starts and other standards end’ though
opinion was divided about whether it was better to ‘cross-
reference to’ other guidelines or ‘integrate with’ them.
‘Perhaps better to defer investigators to these existing
guidelines when methods of study (RCT, observational)
overlap with existing guidelines’ [Open round comment]‘A review and compilation of the relevant CONSORT
statements and extensions should be used to expand
the starting list’ [Open round comment]
Discussion
Summary of findings
We found consensus on 35 items as priority items for
reporting implementation studies and also identified a
Table 2 The 35 items which achieved consensus
Section Standard Consensus (% agreement
with scores 7, 8 or 9)
Title and abstract There should be a structured abstract which clearly states aim, study design, setting, population,
intervention, outcomes, conclusion and implications.
95%
Introduction Identify the aspect of care that the new service being implemented aims to address (e.g.
implementing a guideline recommendation or evidence-based management).
90%
Critically report the evidence underpinning the new service to be implemented: (e.g. phase III
randomised controlled trials, systematic review, guideline recommendations).
100%
Describe the rationale for the new service design. 95%
Report the implementation strategy used and its underpinning theory. 84%
Clearly define the aims of the study, differentiating between implementation (process) objectives
and effectiveness (clinical) objectives.
100%
Method (setting) Describe the study setting (including health service, personnel involved, patient and public
involvement, demography of patients, etc.).
100%
Give year(s) during which the new service was implemented (i.e. planned, initiated and actively
developed) and followed up.
95%
Methods (the
new service)
Describe the new service (e.g. components/content, frequency, duration, intensity, mode of delivery,
materials used) with advice on accessing additional detailed information. Use of a standardised
checklist (e.g. TIDieR) is recommended.
100%
Describe the professional backgrounds, roles and training requirements of the personnel involved
in delivering the intervention with advice on accessing additional detailed information.
84%
Define the core components of the intervention, and the processes for assessing fidelity to
this core content, and what, if any, local adaptation was allowed.
100%
Describe the intervention received by control/comparator group not simply stating ‘usual care’. 95%
Methods
(population)
Describe sites invited/excluded with reasons. 100%
Describe the population targeted by the intervention and any eligibility criteria. 100%
Report method by which patients are referred to or access the new service. 100%
Methods
(randomisation)
Description of randomisation (or if not randomised how comparator group was selected). 95%
Methods (data) Describe outcome measurements (specifically describing any that are at population level)
distinguishing between process and clinical outcomes and health economic data.
100%
Describe data collection processes (specifically including methods of extracting routine data). 100%
Describe any processes for quality assurance (especially for use of routine data). 84%
Methods
(analysis)
Describe power calculation and rationale for sample size. 100%
Describe methods of statistical analysis (with reasons for that choice including approach to
clustering, handling of missing data, intention to treat analysis, and adjustment for confounders,
etc.).
100%
Specify a priori sub-group analyses (e.g. between different sites in a multicentre study, different
clinical or demographic populations).
95%
Results
(population)
Report the number of sites approached, reasons for non-participation and characteristics of
participating sites.
89%
Report the total eligible population (e.g. number of people with the relevant condition registered
with the practice, or eligible for a service), number approached and any exclusions.
100%
Report participation rate among the eligible population, compare characteristics with the eligible
population as a whole and describe any known reasons for non-participation.
95%
Report compliance with/attrition from the service as a process outcome. 95%
Include a CONSORT diagram (modified as necessary) to illustrate the recruitment of sites, provision
of service to patients and any sub-groups.
84%
Results (fidelity) Report fidelity to the core components of the planned intervention (including, in multicentre
studies, in the different settings).
100%
Report any modifications or adaptations to the new service during the course of the study. 100%
Results
(outcomes)
Report outcomes for the whole eligible population before an analysis of any sub-groups. 100%
Report process and clinical outcomes. 100%
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Table 2 The 35 items which achieved consensus (Continued)
If relevant, report impact on use of health service resources (and ideally cost of the intervention). 84%
Report any unintended consequences or adverse effects. 100%
Discussion Interpret findings in the light of the general body of literature and consider implications for health
care services (including issues of generalizability, transferability, strategies for facilitating and
normalising into routine care).
100%
General Include statement(s) on regulatory approvals (including, as appropriate, ethical approval, confidential
use of routine data, governance approval), trial/study registration, funding and conflicts of interest.
89%
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themes included balancing the need for a detailed de-
scription of complex implementation interventions with
the practical demands of writing a concise paper, reflect-
ing the dual aims of reporting the implementation
process and effectiveness of the intervention and moni-
toring fidelity to an intervention whilst enabling modifi-
cation/adaptation to suit the local context of different
centres.Strengths and limitations
In line with recognised methodology [23], our study
adopted a systematic approach to generate potential
standards drawing on both existing literature and expert
opinion. A key strength was the breadth of expertise
within our international multidisciplinary panel, though
we acknowledge that we may not have encompassed all
possible perspectives.Table 3 Items which did not achieve consensus
Section Standard
Title and abstract The title (or abstract if word count of title precludes) sho
methodology (e.g. phase IV implementation study, cluste
interrupted time series, before and after, stepped wedge
Introduction Include a description of the wider health care/policy/com
Describe any pilot implementation work and the conclus
Methods (the
new service)
What is the relation of components of the intervention t
and/or theory underpinning implementation discussed a
Define role of the researchers in design and implementa
Methods
(population)
If applicable, describe any consent required (which shoul
research).
Describe recruitment of any sub-groups recruited for add
completion, physiological measures, detailed record anal
Results
(population)
Report details of any subgroups recruited to specific rese
physiological testing) as opposed to the clinical service. C
to the whole eligible population.
Discussion
(population)
Include a structured abstract (for example including sum
comparison with other studies, conclusions and implicati
Reflect on the processes of implementing the service, ba
How did the setting enable or hinder the implementatio
How was the new service was implemented highlighting
over time and the impact on treatment outcomes and uWe systematically considered all the suggestions from
the open round and revised the list of potential stan-
dards accordingly in order to reflect the insights pro-
vided by the expert panel. Graphical representations of
the median scores and the spread of first round scores
were fed back to participants to facilitate the process of
achieving consensus in the second round. Despite our
explicit emphasis during recruitment on the importance
of committing to the complete consensus exercise, three
participants only contributed to the open round and one
respondent withdrew between the two scoring rounds.
Interpretation
The importance of a detailed description of an interven-
tion has previously been emphasised in the context of
RCTs [34-36]. The comments from our expert panel
suggest that this is an even more complex challenge for
authors of papers reporting implementation studies in
which a core intervention may (or possibly should)Consensus (% agreement
with scores 7, 8 or 9)
uld include a description of the
r randomised implementation trial,
study).
79%
mercial context. 58%
ions from that work. 63%
o the rationale for the new service design
bove?
30%
tion. 79%
d be to the new service and not to 53%
itional research tasks (e.g. questionnaire
ysis).
47%
arch tasks (e.g. questionnaire completion,
ompare characteristics of any sub-groups
74%
mary of findings, strengths and limitations,
ons).
58%
rriers or facilitators and lessons learned. 79%
n of the new service? 79%
(if relevant) variations between sites and
nintended consequences?
74%
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sity of sites. Adoption of innovative strategies for de-
scribing interventions, such as graphical representation
[34], and long-term repositories potentially linked to the
trial registration number for additional materials (includ-
ing, for example, videos, manuals and tools used to as-
sess fidelity in studies) [35,36]. Use of standardised
taxonomies [5,36] may be of particular benefit in enab-
ling full descriptions of the implementation process.
A key issue highlighted by our respondents was the
large number of existing reporting standards [13] and
the increasing potential for overlap between them. Hav-
ing too many checklists potentially causes confusion as
authors and editors are required to select the correct
guideline: too few and researchers working with less
common methodologies may be forced to ‘shoehorn’
their publication into inappropriate but recognised
formats.
Reporting standards are inherently linked with meth-
odology. Methodological considerations will determine
standards, but equally, requirements for reporting may
influence researchers as they design their studies. In the
context of implementation studies, StaRI reporting
guidelines not only build on but may also contribute to
further revisions of the MRC framework which currently
focuses on the development and evaluation of complex
interventions [1]. The framework identifies some ‘prom-
ising approaches’ to effective dissemination, identifies
the need for and offers two examples of implementation
studies [37,38], but does not provide detailed guidance.
Reporting standards represent expert opinion on key
methodological approaches, which may help inform an
extension of the MRC framework [11].
Guidelines and comparative effectiveness programmes
[39,40] typically prioritise RCTs and rarely recognise the
significance of implementation studies in informing
health care practice. Poor reporting only exacerbates this
problem as potentially important implementation work
is either not identified or its importance downgraded.
Conclusions
The starting point for the StaRI work was the recogni-
tion of the poor standard of reporting of implementation
work [5,11]. This literature review and e-Delphi exercise
represents the first two stages in developing agreed
international standards. A workshop is planned in
Spring 2015 that will have the remit to discuss the over-
arching issues, clarify specific items and develop StaRI
reporting standards to fit within the suite of EQUATOR
reporting guidelines. If adopted by authors and enforced
by editors, the standard should promote consistent
reporting of implementation research that can inform
health services and health care professionals seeking to
implement research findings into routine clinical care.Abbreviations
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